Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasms 9Head and Neck Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Advanced Malignancies 1

Interventions

parsaclisib 2cemiplimab 2Midazolam 2MLN 8237 2Injections 2tanespimycin 1spartalizumab 1repaglinide 1epothilone B 1drospirenone 1cabiralizumab 1Pemetrexed 1Paclitaxel 1Nivolumab 1N-alpha-(2,4,6-triisopropyl-phenylsulfonyl)-3-amidino-(L)-phenyl-alanine-4-ethoxycarbonyl-piperazide hydrochloride 1MLN8054 1Ipilimumab 1Gemcitabine 1Ethinyl Estradiol 1Drug Therapy 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Advanced Malignancies × epothilone B × Clear all
NCT00426140 2020-12-08

Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies.

Novartis

Phase 1 Completed
5 enrolled
Other solid neoplasm

Advanced Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡